Hims & Hers Health Operating Income 2020-2026 | HIMS
Hims & Hers Health annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Hims & Hers Health operating income for the quarter ending June 30, 2026 was $-0.097B, a 463.7% decline year-over-year.
- Hims & Hers Health operating income for the twelve months ending June 30, 2026 was $-0.155B, a 223.04% decline year-over-year.
- Hims & Hers Health annual operating income for 2025 was $0.106B, a 70.61% increase from 2024.
- Hims & Hers Health annual operating income for 2024 was $0.062B, a 310.18% decline from 2023.
- Hims & Hers Health annual operating income for 2023 was $-0.029B, a 57.13% decline from 2022.
|
Hims & Hers Health Annual Operating Income (Millions of US $) |
|
|---|---|
| 2025 | $106 |
| 2024 | $62 |
| 2023 | $-29 |
| 2022 | $-69 |
| 2021 | $-115 |
| 2020 | $-15 |
| 2019 | $-74 |
|
Hims & Hers Health Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2026-06-30 | $-97 |
| 2026-03-31 | $-78 |
| 2025-12-31 | $9 |
| 2025-09-30 | $12 |
| 2025-06-30 | $27 |
| 2025-03-31 | $58 |
| 2024-12-31 | $19 |
| 2024-09-30 | $22 |
| 2024-06-30 | $11 |
| 2024-03-31 | $10 |
| 2023-12-31 | $0 |
| 2023-09-30 | $-9 |
| 2023-06-30 | $-9 |
| 2023-03-31 | $-11 |
| 2022-12-31 | $-12 |
| 2022-09-30 | $-20 |
| 2022-06-30 | $-20 |
| 2022-03-31 | $-17 |
| 2021-12-31 | $-22 |
| 2021-09-30 | $-28 |
| 2021-06-30 | $-17 |
| 2021-03-31 | $-48 |
| 2020-12-31 | $-5 |
| 2020-09-30 | $-3 |
| 2020-06-30 | $-1 |
| 2020-03-31 | $-6 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $6.507B | $2.348B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $42.703B | 42.61 |
| Tempus AI (TEM) | United States | $14.500B | 0.00 |
| 10x Genomics (TXG) | United States | $10.029B | 0.00 |
| Hinge Health (HNGE) | United States | $7.643B | 73.43 |
| Doximity (DOCS) | United States | $4.736B | 29.20 |
| Heartflow (HTFL) | United States | $4.310B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.684B | 242.93 |
| Privia Health (PRVA) | United States | $2.566B | 95.67 |
| Clover Health Investments (CLOV) | United States | $2.411B | 0.00 |
| Schrodinger (SDGR) | United States | $2.232B | 0.00 |
| Butterfly Network (BFLY) | United States | $2.120B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.103B | 32.04 |
| Omnicell (OMCL) | United States | $1.484B | 21.18 |
| Azenta (AZTA) | United States | $1.473B | 80.07 |
| Enovis (ENOV) | United States | $1.027B | 5.31 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.716B | 0.00 |
| Phreesia (PHR) | United States | $0.638B | 34.27 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Veradigm (MDRX) | United States | $0.587B | 0.00 |
| Claritev (CTEV) | United States | $0.538B | 0.00 |
| Carlsmed (CARL) | United States | $0.420B | 0.00 |
| Evolent Health (EVH) | United States | $0.415B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.394B | 0.00 |
| CapsoVision (CV) | United States | $0.317B | 0.00 |
| Standard BioTools (LAB) | United States | $0.287B | 0.00 |
| American Well (AMWL) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.135B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.129B | 0.00 |
| CareCloud (CCLD) | United States | $0.094B | 6.94 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Outset Medical (OM) | United States | $0.058B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.058B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.047B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.033B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.027B | 0.00 |
| HeartBeam (BEAT) | United States | $0.024B | 0.00 |
| HeartSciences (HSCS) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |